OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
160156

Zhongguancun Science-Tech Leasing Co Ltd

Corporate Financial ServicesVerified

Zhongguancun Science-Tech Leasing Co Ltd maintains a debt-to-equity ratio of 2.21, indicating a capital structure that is heavily leveraged. The company's liquidity position is characterized as medium, with a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited buffer. Free cash flow is negative at -81.08 million CNY, reflecting cash outflows from operations after capital expenditures. The company's profitability is reflected in a return on equity (ROE) of 8.33% and a return on assets (ROA) of 2.07%. These figures are below the industry median for ROE and ROA in the Corporate Financial Services sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. Zhongguancun Science-Tech Leasing Co Ltd operates primarily in the domestic market, with a focus on the technology and new economy sectors, including artificial intelligence, double carbon, medicine and health, intelligent manufacturing, and new consumption. The company's revenue is concentrated in these sectors, with no disclosed diversification into international markets or other economic segments. The company's growth trajectory is modest, with no disclosed revenue growth in the most recent fiscal year. The outlook for the next fiscal year is neutral, with no significant changes expected in revenue or operating income. Capital expenditures are expected to remain a drag on cash flow, with a projected outflow of 314.81 million CNY. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's reliance on debt financing and potential exposure to refinancing risk. The company has not disclosed any dilution sources in the near term, and no adjustments have been applied to the valuation metrics. Recent events include the company's continued focus on science and technology innovation enterprises, with no material changes in its business model or strategic direction. The company has not disclosed any significant regulatory or legal challenges in the most recent filings or transcripts.

30-day price · 1601-0.02 (-2.4%)
Low$0.82High$0.86Close$0.83As of15 May, 00:00 UTC
Profile
CompanyZhongguancun Science-Tech Leasing Co Ltd
Ticker1601.HK
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryCorporate Financial Services
AI analysis

Business. Zhongguancun Science-Tech Leasing Co Ltd provides financial leasing and consulting services to science and technology innovation enterprises, focusing on equipment financing, intellectual property leasing, and project leasing.

Classification. Zhongguancun Science-Tech Leasing Co Ltd is classified under the Financials economic sector, Banking & Investment Services business sector, and Corporate Financial Services industry with a confidence level of 0.92.

Zhongguancun Science-Tech Leasing Co Ltd maintains a debt-to-equity ratio of 2.21, indicating a capital structure that is heavily leveraged. The company's liquidity position is characterized as medium, with a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited buffer. Free cash flow is negative at -81.08 million CNY, reflecting cash outflows from operations after capital expenditures. The company's profitability is reflected in a return on equity (ROE) of 8.33% and a return on assets (ROA) of 2.07%. These figures are below the industry median for ROE and ROA in the Corporate Financial Services sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. Zhongguancun Science-Tech Leasing Co Ltd operates primarily in the domestic market, with a focus on the technology and new economy sectors, including artificial intelligence, double carbon, medicine and health, intelligent manufacturing, and new consumption. The company's revenue is concentrated in these sectors, with no disclosed diversification into international markets or other economic segments. The company's growth trajectory is modest, with no disclosed revenue growth in the most recent fiscal year. The outlook for the next fiscal year is neutral, with no significant changes expected in revenue or operating income. Capital expenditures are expected to remain a drag on cash flow, with a projected outflow of 314.81 million CNY. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's reliance on debt financing and potential exposure to refinancing risk. The company has not disclosed any dilution sources in the near term, and no adjustments have been applied to the valuation metrics. Recent events include the company's continued focus on science and technology innovation enterprises, with no material changes in its business model or strategic direction. The company has not disclosed any significant regulatory or legal challenges in the most recent filings or transcripts.
Key takeaways
  • The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.21.
  • ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in the domestic technology and new economy sectors, with no international diversification.
  • Free cash flow is negative, and capital expenditures are expected to remain a drag on liquidity.
  • The company has low dilution risk and no disclosed dilution sources in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$852.7M
Gross profit
Operating income$590.5M
Net income$272.0M
R&D
SG&A
D&A
SBC
Operating cash flow$736.7M
CapEx-$314.8M
Free cash flow-$81.1M
Total assets$13.11B
Total liabilities$9.85B
Total equity$3.27B
Cash & equivalents$699.7M
Long-term debt$7.23B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.27B
Net cash-$6.53B
Current ratio1.2
Debt/Equity2.2
ROA2.1%
ROE8.3%
Cash conversion2.7%
CapEx/Revenue-36.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking · cohort 1 companies
Metric1601Activity
Op margin69.3%27.8% medp25 11.0% · p75 56.0%top quartile
Net margin31.9%30.4% medp25 30.4% · p75 30.4%top quartile
Gross margin63.4% medp25 42.7% · p75 94.6%
CapEx / revenue-36.9%19.6% medp25 19.6% · p75 19.6%bottom quartile
Debt / equity221.0%590.5% medp25 317.2% · p75 863.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 15:49 UTC#78d4e70f
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 15:52 UTCJob: b230fbce